Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

BIOL

Biolase Inc

Jun 12 • 04:00PM ET

0.1490

Dollar change -0.0070
Percentage change -4.49	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-20.55	Insider Own	3.94%	Shs Outstand	33.40M	Perf Week	-3.25%
Market Cap	4.98M	Forward P/E	-	EPS next Y	-0.10	Insider Trans	0.00%	Shs Float	32.08M	Perf Month	-17.63%
Income	-38.26M	PEG	-	EPS next Q	-0.07	Inst Own	5.41%	Short Float	6.54%	Perf Quarter	7.97%
Sales	48.83M	P/S	0.10	EPS this Y	98.51%	Inst Trans	1.35%	Short Ratio	0.44	Perf Half Y	-87.16%
Book/sh	-0.06	P/B	-	EPS next Y	78.41%	ROA	-55.75%	Short Interest	2.10M	Perf Year	-98.09%
Cash/sh	0.19	P/C	0.78	EPS next 5Y	20.00%	ROE	-683.42%	52W Range	0.13 - 10.31	Perf YTD	-86.72%
Dividend Est.	-	P/FCF	-	EPS past 5Y	59.23%	ROI	-318.31%	52W High	-98.55%	Beta	0.77
Dividend TTM	-	Quick Ratio	0.64	Sales past 5Y	7.86%	Gross Margin	34.25%	52W Low	19.10%	ATR (14)	0.02
Dividend Ex-Date	Jun 24, 2005	Current Ratio	1.17	EPS Y/Y TTM	94.07%	Oper. Margin	-35.17%	RSI (14)	44.44	Volatility	6.43% 11.46%
Employees	157	Debt/Eq	-	Sales Y/Y TTM	0.13%	Profit Margin	-78.35%	Recom	1.67	Target Price	1.95
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	97.96%	Payout	-	Rel Volume	0.25	Prev Close	0.16
Sales Surprise	-1.92%	EPS Surprise	-111.76%	Sales Q/Q	-3.21%	Earnings	May 13 AMC	Avg Volume	4.79M	Price	0.15
SMA20	-8.66%	SMA50	-6.43%	SMA200	-85.20%	Trades		Volume	1,192,170	Change	-4.49%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-19-19	Initiated	The Benchmark Company	Speculative Buy	$2
Apr-25-17	Initiated	Singular Research	Buy	$2.50
May-13-14	Downgrade	WallachBeth	Buy → Hold	$4 → $2.50
Nov-12-13	Reiterated	WallachBeth	Buy	$3.50 → $2.75
Aug-08-13	Reiterated	WallachBeth	Buy	$6.50 → $4.50
Jun-17-13	Initiated	WallachBeth	Buy	$6.50
Mar-18-13	Reiterated	Northland Capital	Outperform	$6 → $7
Mar-07-13	Reiterated	Northland Capital	Outperform	$6 → $7
Sep-07-12	Initiated	Northland Securities	Outperform	$4

May-14-24 07:29AM	Q1 2024 BIOLASE Inc Earnings Call (Thomson Reuters StreetEvents) -14.87%
03:02AM	Biolase Inc (BIOL) Q1 2024 Earnings Call Transcript Highlights: Strategic Gains Amidst Economic ... (GuruFocus.com)
May-13-24 08:53PM	BIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +7.10%
04:17PM	Biolase: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability (ACCESSWIRE)
06:30AM	Loading…
May-06-24 06:30AM	BIOLASE to Report First Quarter 2024 Results on May 13, 2024 (ACCESSWIRE) +21.85%
Mar-23-24 09:53AM	BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-22-24 06:19AM	Q4 2023 BIOLASE Inc Earnings Call (Thomson Reuters StreetEvents) +19.53%
Mar-21-24 08:53PM	BIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:48PM	Biolase: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 (ACCESSWIRE)
Mar-14-24 06:30AM	BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 (ACCESSWIRE)
Feb-22-24 06:30AM	Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry (ACCESSWIRE) +6.00%
Feb-20-24 06:30AM	Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental' (ACCESSWIRE)
Feb-15-24 02:45PM	BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering (ACCESSWIRE)
06:30AM	Loading…
Feb-14-24 06:30AM	BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement (ACCESSWIRE) -8.83%
Feb-13-24 09:15AM	BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering (ACCESSWIRE) -63.18%
Jan-29-24 06:30AM	BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024 (PR Newswire) -7.28%
Jan-08-24 04:05PM	BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023 (PR Newswire)
Jan-03-24 04:05PM	BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD (PR Newswire)
Dec-14-23 04:05PM	BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD (PR Newswire) -7.20%
Dec-12-23 04:05PM	BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial (PR Newswire) +6.90%
Dec-06-23 01:46PM	BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (PR Newswire)
Nov-09-23 04:45PM	Biolase: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES (PR Newswire)
Nov-08-23 06:30AM	Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR Perio Protocol (PR Newswire) -6.65%
Nov-07-23 04:05PM	BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023 (PR Newswire) -5.39%
Oct-18-23 08:00AM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (PR Newswire)
Sep-18-23 04:30PM	BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants (PR Newswire)
Sep-13-23 11:16PM	BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants (PR Newswire) -8.43%
05:26AM	Loading…
Aug-11-23 05:26AM	Q2 2023 BIOLASE Inc Earnings Call (Thomson Reuters StreetEvents) -13.87%
Aug-10-23 04:29PM	Biolase: Q2 Earnings Snapshot (Associated Press Finance) -6.55%
04:05PM	BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR (PR Newswire)
Aug-02-23 04:05PM	BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10, 2023 (PR Newswire) -12.65%
Jul-26-23 04:30PM	BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT (PR Newswire) -7.36%
Jul-17-23 06:30AM	BIOLASE EPIC HYGIENE DENTAL LASER RECEIVES PRESTIGIOUS CELLERANT BEST OF CLASS HYGIENE AWARD (PR Newswire) -5.64%
Jun-15-23 06:30AM	BIOLASE Announces Grand Opening of Training Facility to Reach Wider Universe of Dental Practitioners; First-Hand Experience Using Leading Dental Laser Technology Expected to Generate Increased Revenue Opportunities (PR Newswire) +9.12%
Jun-14-23 04:05PM	BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2023 VIRTUAL HEALTHCARE CONFERENCE HOSTED BY M-VEST ON JUNE 20TH - 22ND (PR Newswire)
06:30AM	BIOLASE INTEGRATES DIODE LASER TECHNOLOGY WITH PET DENTAL SERVICES (PR Newswire)
Jun-05-23 05:30PM	BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK (PR Newswire) -8.56%
06:30AM	BIOLASE Takes Steps to Improve Operating Efficiency as the Company Pursues Sales and Profitability Goals (PR Newswire)
May-26-23 11:25AM	BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants (PR Newswire)
May-24-23 09:14AM	BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants (PR Newswire) -39.91%
May-11-23 04:36PM	Biolase: Q1 Earnings Snapshot (AP Finance) +26.33%
04:21PM	BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023 (PR Newswire)
May-04-23 04:05PM	BIOLASE TO REPORT FIRST QUARTER 2023 RESULTS ON MAY 11, 2023 (PR Newswire)
Mar-30-23 07:59AM	BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript (Insider Monkey) -7.63%
Mar-28-23 04:16PM	Biolase: Q4 Earnings Snapshot (AP Finance)
04:05PM	BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH AND PROFITABILITY IN 2023 (PR Newswire)
Mar-14-23 06:30AM	BIOLASE GATHERS KEY OPINION LEADERS AND DENTAL CLINICIANS TO HIGHLIGHT TONGUE-TIE TREATMENT BEST PRACTICES (PR Newswire)
Mar-13-23 06:30AM	BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2022 RESULTS ON MARCH 28, 2023 (PR Newswire)
Mar-06-23 06:30AM	BIOLASE PLANS TO LAUNCH SEASON 2 OF ITS POPULAR PODCAST SERIES (PR Newswire)
Feb-27-23 06:30AM	BIOLASE LAUNCHES E-COMMERCE SITE TO ENHANCE POSITIVE USER EXPERIENCE AND STREAMLINE THE PURCHASING PROCESS TO CREATE GREATER EFFICIENCIES FOR DENTAL PRACTITIONERS (PR Newswire) +5.11%
Feb-23-23 06:30AM	BIOLASE ENTERS THE SKIN RESURFACING MARKET IN THE U.S. WITH THE LAUNCH OF A NEW WATERLASE FRACTIONAL HANDPIECE (PR Newswire)
Feb-21-23 06:30AM	BIOLASE FURTHER ENHANCES MARKET AWARENESS CAMPAIGN WITH THE MUCH ANTICIPATED LAUNCH OF NEW EDUCATION PORTAL (PR Newswire) -8.90%
Feb-16-23 06:00PM	BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE (PR Newswire)
Feb-09-23 04:05PM	BIOLASE RECEIVES SECOND TOP WORKPLACES 2022 AWARD (PR Newswire) -8.70%
Jan-31-23 08:00AM	SWK Holdings Provides Portfolio Update Highlighting Recent Achievements (PR Newswire)
Jan-25-23 06:30AM	BIOLASE REJECTS SONENDO'S "PATENTLY ABSURD" CLAIMS (PR Newswire) -7.74%
Jan-18-23 06:00AM	BIOLASE MAINTAINS POSITIVE MOMENTUM THROUGH YEAR END WITH SOLID FOURTH QUARTER REVENUE GROWTH; SIGNIFICANT MARKET OPPORTUNITY AND INDUSTRY-LEADING PRODUCT SUPPORT EXPECTATION FOR ROBUST REVENUE GROWTH IN 2023 (PR Newswire)
Jan-12-23 04:05PM	BIOLASE RECEIVES TOP WORKPLACES 2022 AWARD (PR Newswire)
Jan-10-23 08:00AM	BIOLASE INC. ANNOUNCES PRICING OF APPROXIMATELY $9.75 MILLION UNDERWRITTEN PUBLIC OFFERING (PR Newswire) -44.95%
Nov-14-22 06:30AM	BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York (PR Newswire) +13.41%
Nov-10-22 04:05PM	BIOLASE DELIVERS 26% REVENUE GROWTH YEAR OVER YEAR IN THIRD QUARTER AND RAISES 2022 FULL YEAR REVENUE GUIDANCE (PR Newswire) +11.35%
Oct-27-22 06:30AM	BIOLASE, Inc to Report Third Quarter 2022 Results on November 10, 2022 (PR Newswire)
Oct-18-22 04:05PM	SWK Holdings Provides Portfolio Update Highlighting Recent Achievements (PR Newswire)
Oct-13-22 06:30AM	BIOLASE NAMES DR. RUSSELL MORROW AS CHIEF DENTAL OFFICER (PR Newswire)
Oct-05-22 06:00AM	BIOLASE LAUNCHES RESEARCH GRANT PORTAL TO ACCELERATE CLINICAL STUDIES ON INNOVATIVE DENTAL LASER TECHNOLOGY (PR Newswire)
Sep-22-22 06:30AM	BIOLASE DOCUSERIES, "TALK DENTAL TO ME" TO BE PRODUCED BY PROVIDENCE FILM GROUP (PR Newswire)
Aug-31-22 06:30AM	BIOLASE ANNOUNCES DEVELOPMENT OF STRATEGIC PLAN TO PARTNER WITH POSTGRADUATE DENTAL SPECIALTY PROGRAMS ACROSS THE U.S. (PR Newswire)
Aug-24-22 04:05PM	BIOLASE TO PARTICIPATE IN THE LAKE STREET 6TH ANNUAL BEST IDEAS GROWTH CONFERENCE SEPTEMBER 14, 2022 (PR Newswire)
Aug-11-22 04:05PM	BIOLASE DELIVERS 34% REVENUE GROWTH YEAR OVER YEAR IN SECOND QUARTER (PR Newswire)
Jul-28-22 06:30AM	BIOLASE, Inc to Report Second Quarter 2022 Results on August 11, 2022 (PR Newswire)
Jul-25-22 06:30AM	BIOLASE EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH NEW UNITED STATES AND FOREIGN PATENTS (PR Newswire) -5.32%
Jul-13-22 06:30AM	BIOLASE ANNOUNCES TRAINING INITIATIVE WITH EINSTEIN HEALTHCARE NETWORK'S GENERAL DENTISTRY RESIDENCY PROGRAM (PR Newswire)
Jul-07-22 06:30AM	BIOLASE ANNOUNCES PROMOTIONS OF KEY TEAM MEMBERS (PR Newswire)
Jul-05-22 06:30AM	BIOLASE ANNOUNCES SUPPORT FOR TEAMSMILE PROGRAM (PR Newswire)
Jun-30-22 07:08PM	BIOLASE ENTERS INTO FAVORABLE CREDIT AGREEMENT AMENDMENT (PR Newswire)
Jun-28-22 08:30AM	BIOLASE Announces Pricing of $6.5 Million Registered Direct Offering Priced At-the-Market (PR Newswire) -9.78%
Jun-27-22 06:30AM	BIOLASE ANNOUNCES SUPPORT FOR PROJECT HOME (PR Newswire) +12.80%
Jun-21-22 06:30AM	BIOLASE ANNOUNCES ADVANCING DENTISTRY WEBINARS FOR Q3 2022 (PR Newswire)
Jun-13-22 06:30AM	BIOLASE ANNOUNCES ADVANCING DENTISTRY PODCAST (PR Newswire) -8.91%
Jun-09-22 06:30AM	BIOLASE ANNOUNCES INAUGURAL CLINICAL EXCELLENCE FORUM (PR Newswire)
Jun-06-22 06:30AM	BIOLASE SIGNS LEASE TO EXPAND TRAINING AND EDUCATION INITIATIVES (PR Newswire)
Jun-02-22 06:30AM	BIOLASE TO PRESENT AT LD MICRO INVITATIONAL INVESTOR CONFERENCE ON JUNE 8, 2022 (PR Newswire)
Jun-01-22 06:30AM	BIOLASE CREATES FIRST-OF-ITS-KIND CLINICAL INTEGRATION TEAM (PR Newswire)
May-24-22 06:30AM	BIOLASE CEO SHARES VISION FOR KINDLER, GENTLER DENTISTRY WITH CUSTOMERS AROUND THE WORLD (PR Newswire)
May-16-22 04:05PM	BIOLASE TO PARTICIPATE IN THE SPRING INTO ACTION BEST IDEAS VIRTUAL INVESTOR CONFERENCE MAY 17-20, 2022 (PR Newswire) -5.76%
01:20PM	36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 (ACCESSWIRE)
06:30AM	BIOLASE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT (PR Newswire)
May-12-22 04:05PM	BIOLASE MAINTAINS GROWTH MOMENTUM AS FIRST QUARTER REVENUE INCREASED 25% YEAR OVER YEAR (PR Newswire) -10.70%
May-09-22 06:30AM	BIOLASE STRENGTHENS ITS BOARD OF DIRECTORS WITH ADDITION OF SEASONED HEALTHCARE EXECUTIVE (PR Newswire) -11.28%
May-04-22 04:05PM	BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022 (PR Newswire) +9.84%
Apr-28-22 03:15PM	BIOLASE ANNOUNCES 1-FOR-25 REVERSE STOCK SPLIT (PR Newswire) -34.20%
Mar-23-22 08:30AM	BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2022 VIRTUAL GROWTH CONFERENCE HOSTED BY M-VEST ON MARCH 28TH - 30TH (PR Newswire)
Mar-17-22 04:05PM	BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021 (PR Newswire) +16.63%
Mar-03-22 06:30AM	BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022 (PR Newswire)
Mar-01-22 04:15PM	BIOLASE Announces Distribution of Series G Preferred Stock to Holders of Its Common Stock (PR Newswire)
Feb-10-22 05:10AM	Is BIOLASE (NASDAQ:BIOL) Using Too Much Debt? (Simply Wall St.)
Jan-28-22 10:07AM	36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022 (ACCESSWIRE)

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BIOL

Biolase Inc

Upgrade your FINVIZ experience